Lilly, Humana in Research Pact

barbara.lempert Humana and Lilly Form Research Collaboration to Improve Health Care Outcomes Companies embark on evidence-based research effort to advance health care outcomes LOUISVILLE, ...

Low-profile Epirus lays claim to a PhIII success for Remicade biosimilar

John Carroll A low-profile startup in Boston backed by some marquee venture groups has posted positive data from a Phase III study of its biosimilar of Remicade, a blockbuster rheumatoid ...

Novartis discount fails to persuade NICE on Afinitor in breast cancer

Tracy Staton To win over U.K. cost-effectiveness gatekeepers, Novartis cut Afinitor's price. Unfortunately for the Swiss drugmaker, it didn't work. The National Institute for ...

BrandPower Ranking: Bayer Among the Most Respected Brands in the U.S.

barbara.lempert Around the world, the Bayer cross (here at Frankfurt Airport) stands for the Bayer brand. Leverkusen, August 28, 2013 – Bayer features among the top ten brands in ...

Astex reports positive PhII results for leukemia drug

Emily Mullin Dublin, CA-based Astex Pharmacueticals revealed Wednesday morning that its small molecule SGI-110 showed "clear activity" in a Phase II trial of patients with ...

Frost & Sullivan: Competition Intensifies as Pharma Companies Race to Launch Type 2 Diabetes Drugs

barbara.lempert Learn which products will eventually succeed and why, in the race against time LONDON – 28th August 2013 – The global pre-diabetes population is three times the ...

Colorful Third Rock crew defines new biotech startup style

John Carroll There's been a considerable amount of moaning and groaning in recent years over the clear lack of capital needed to start up a biotech. But Third Rock Ventures has ...

Indian official disputes Novartis chief’s patent complaints

Tracy Staton Novartis CEO Joe Jimenez wrote to Indian Commerce and Industry Minister Anand Sharma, accusing the government of favoring domestic companies over multinationals in its ...

Lipidor reports positive clinical Phase I/II data in psoriasis

barbara.lempert STOCKHOLM – August 27, 2013. Today Lipidor announced positive results from a Phase I/IIa study investigating the efficacy and tolerability of its AKVANO®/calcipotriol ...

Roche’s gRED sees promising results in PhII macular degeneration study

John Carroll Investigators say that lampalizumab slowed progression of AMD in patients with advanced disease, shrinking the area of geographic atrophy by 20.4%. AMD is a leading cause ...

iCo Therapeutics Announces Second Quarter 2013 Financial Results

barbara.lempert VANCOUVER, Aug. 26, 2013 /CNW/ – iCo Therapeutics (TSX-V: ICO), today reported financial results for the quarter ended June 30, 2013. Amounts, unless specified ...

NIH: Gilead’s sofosbuvir cures some of the toughest hepatitis C cases

John Carroll An NIH-sponsored study of Gilead's sofosbuvir combined with ribavirin demonstrated that the experimental therapy provided a "safe and effective" interferon-free ...
Page 2 of 3812345...102030...Last »
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS